Amendment to Schedule 13D Filing for Royalty Pharma plc

This filing is an amendment to a Schedule 13D originally filed on June 29, 2020, regarding Class A Ordinary Shares of Royalty Pharma plc. The amendment, filed by R & H Trust Co. (Guernsey) Limited and Achille G. Severgnini, details changes in beneficial ownership as of February 19, 2026. Collectively, the Reporting Persons beneficially own 24,223,082 Class A Shares, representing 5.7% of the outstanding shares. The filing also discloses transactions in Class A Shares by MGG Strategic and GG Strategic within the 60-day period prior to November 6, 2025, and up to February 19, 2026. These transactions involved sales of shares at prices ranging from $39.50 to $45.905. Additionally, the filing references an amendment to a facility agreement where the pledge of Class A Shares as collateral was lowered, and the available committed facility amount was reduced.